STOCK TITAN

SPRBD Financials

SPRBD
FY2025 annual
Revenue $0 -100.0% YoY
Net Income -$39.0M +26.5% YoY
EPS (Diluted) -$50.83 YoY not available
Operating Cash Flow -$33.3M +40.4% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-K for Q1 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SPRBD SEC filings page.

SPRBD (SPRBD) reported $0 in revenue for fiscal year 2025, down 100.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SPRBD FY2025

External financing supports a development-heavy model while reported revenue remains small, uneven, and secondary to research spending.

In FY2025, operating cash flow was -$33.3M against a net loss of -$39.0M, so accounting losses did not translate one-for-one into cash consumption. However, financing cash flow of $43.5M exceeded the year's operating cash outflow of $33.3M, making capital funding—not customer receipts—the primary cash source.

FY2024 revenue was $4.9M against R&D of $46.4M, so the reported cost base was built around development rather than current sales. That imbalance makes operating losses structural to the present model, not a conventional gross-margin problem.

With no long-term debt and a 5.2x current ratio in FY2025, the balance sheet is lightly debt-funded. Yet the combination of negative operating cash flow and substantial financing inflow shows liquidity is being supported externally rather than generated by operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

SPRBD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
4/8

SPRBD passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

SPRBD reported a net loss of $39.0M while operations used $33.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

SPRBD reported an operating loss of $36.5M against $90K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA
-$11.7M
YoY+19.0%

SPRBD's EBITDA was -$11.7M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.0% from the same quarter a year earlier.

Net Income
-$12.3M
YoY+12.6%

SPRBD reported -$12.3M in net income in Q1 2026. This represents an increase of 12.6% from the same quarter a year earlier.

EPS (Diluted)
-$8.94

SPRBD earned -$8.94 per diluted share (EPS) in Q1 2026.

Revenue

Not reported for Q1 2026.

Cash & Balance Sheet

Free Cash Flow
-$8.7M
YoY+31.3%

SPRBD recorded an outflow of $8.7M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents an increase of 31.3% from the same quarter a year earlier.

Cash & Debt
$54.1M
YoY+111.1%
QoQ+10.6%
5Y CAGR-18.3%

SPRBD held $54.1M in cash against $5.5M in long-term debt as of Q1 2026.

Shares Outstanding
1M
QoQ0.0%
5Y CAGR-43.2%

SPRBD had 1M shares outstanding in Q1 2026. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Return on Equity
-35.4%
YoY+56.2pp

SPRBD's ROE was -35.4% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 56.2 percentage points from the same quarter a year earlier.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Net Margin

Not reported for Q1 2026.

Capital Allocation

R&D Spending
$7.6M
YoY-30.1%

SPRBD invested $7.6M in research and development in Q1 2026. This represents a decrease of 30.1% from the same quarter a year earlier.

Capital Expenditures
$10K

SPRBD invested $10K in capex in Q1 2026, funding long-term assets and infrastructure.

Share Buybacks

Not reported for Q1 2026.

SPRBD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRBD quarterly income statement
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'25Q1'25Q4'2410-KQ3'2410-QQ2'24
RevenueN/AN/A$0-100.0%$0-100.0%$0-100.0%$697K-75.9%$602K-80.4%$1.6M-25.6%
R&D Expenses$7.6M-30.1%N/A$5.0M-23.5%-$430K-94.7%$10.8M+5.0%$21.5M+93.3%$6.6M-51.4%$8.1M-38.4%
SG&A Expenses$4.4M+20.7%N/A$3.2M-6.9%$3.1M-12.2%$3.7M-15.4%$3.3M+12.3%$3.5M+6.8%$3.6M+18.1%
Operating Income-$12.0M+17.3%N/A-$8.2M+12.5%-$2.7M+73.2%-$14.5M-14.7%-$24.1M-115.6%-$9.4M+31.1%-$10.0M+28.2%
EBITDA-$11.7M+19.0%N/AN/AN/A-$14.5M-14.8%N/AN/AN/A
Interest Expense$674K+1772.2%N/A$19K-73.2%$29K-65.1%$36K-62.9%$56K-47.2%$71K-40.3%$83K-34.6%
Net Income-$12.3M+12.6%N/A-$8.2M+5.3%-$2.1M+77.5%-$14.0M-20.8%-$23.6M-136.8%-$8.7M+29.8%-$9.2M+28.4%
EPS (Basic)-$8.94+62.7%N/A-$14.58+7.4%-$3.50+79.1%-$23.95-8453.6%N/A-$15.75-5150.0%-$16.73-5128.1%
EPS (Diluted)-$8.94N/A-$14.58-$3.50-$23.95N/A-$15.75-$16.73
Diluted Shares (Avg)1MN/A563,066591,137586,142N/A550,645548,789

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Income Tax.

SPRBD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRBD quarterly balance sheet
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'25Q1'25Q4'2410-KQ3'2410-QQ2'24
Total Assets$56.2M+77.5%$53.0M+17.3%$15.3M-76.5%$21.8M-71.1%$31.6M-63.8%$45.2M-56.5%$65.1M-42.4%$75.5M-40.0%
Current Assets$55.0M+80.0%$52.1M+17.9%$14.5M-77.2%$21.0M-71.7%$30.6M-64.4%$44.2M-56.7%$63.6M-42.8%$73.9M-40.5%
Cash & Equivalents$54.1M+111.1%$48.9M+26.2%$10.7M-82.2%$16.4M-76.5%$25.6M-68.4%$38.8M-59.8%$60.1M-39.2%$69.7M-28.5%
Total Liabilities$21.5M+31.8%$10.5M-35.9%$9.9M-26.3%$8.6M-47.2%$16.3M-21.9%$16.4M-40.3%$13.5M-51.2%$16.4M-44.4%
Current Liabilities$11.8M-24.8%$10.1M-33.8%$9.4M-20.5%$8.1M-43.6%$15.7M-14.8%$15.2M-37.7%$11.9M-51.0%$14.3M-37.2%
Non-Current Liabilities$9.7M+1377.1%$419K-63.3%$500K-68.9%$580K-71.9%$659K-73.9%$1.1M-61.6%$1.6M-53.0%$2.1M-69.0%
Long-Term Debt$5.5M$0-100.0%$0-100.0%$0-100.0%$0-100.0%$124K-92.8%$524K-75.2%$923K-63.2%
Total Equity$34.6M+126.1%$42.5M+47.5%$5.4M-89.6%$13.2M-77.7%$15.3M-77.0%$28.8M-62.3%$51.6M-39.5%$59.2M-38.7%
Retained Earnings-$301.5M-14.1%-$289.2M-15.6%-$274.6M-21.1%-$266.4M-22.2%-$264.3M-26.6%-$250.3M-26.9%-$226.7M-21.1%-$218.0M-24.6%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill.

SPRBD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRBD quarterly cash flow statement
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'25Q1'25Q4'2410-KQ3'2410-QQ2'24
Operating Cash Flow-$8.7M+31.4%-$6.5M+68.8%-$5.3M+42.4%-$8.8M+20.5%-$12.7M+14.9%-$20.7M-84.5%-$9.2M+24.8%-$11.1M-657.3%
Depreciation & Amortization$252K+4100.0%N/AN/AN/A$6K-60.0%N/AN/AN/A
Stock-Based Compensation$689K+26.7%N/A$415K-63.6%-$77K-104.6%$544K-65.2%N/A$1.1M+1.6%$1.7M+38.2%
Capital Expenditures$10KN/AN/AN/A$0$0N/AN/A
Free Cash Flow-$8.7M+31.3%N/AN/AN/A-$12.7M-$20.7M-84.5%N/AN/A
Investing Cash Flow-$10KN/AN/AN/A$0$0-100.0%$0-100.0%$0-100.0%
Financing Cash Flow$13.9M+3485.9%$44.7M+7251.0%-$402K+0.7%-$400K-9.6%-$411K-81.1%-$625K-13.2%-$405K0.0%-$365K+15.5%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

SPRBD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPRBD quarterly financial ratios
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'25Q1'25Q4'2410-KQ3'2410-QQ2'24
Operating MarginN/AN/AN/AN/AN/A-3453.9%-1562.8%-623.4%
Net MarginN/AN/AN/AN/AN/A-3380.1%-1440.4%-570.3%
Return on Equity-35.4%+56.2ppN/A-152.5%-135.7pp-15.7%-0.2pp-91.6%-74.2pp-81.7%-68.7pp-16.8%-2.3pp-15.5%-2.2pp
Return on Assets-21.8%+22.5ppN/A-53.6%-40.3pp-9.5%+2.7pp-44.4%-31.1pp-52.1%-42.5pp-13.3%-2.4pp-12.2%-2.0pp
Current Ratio4.67+2.7x5.17+2.3x1.54-3.8x2.60-2.6x1.95-2.7x2.90-1.3x5.36+0.8x5.17-0.3x
Debt-to-Equity0.16+0.2x0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.010.0x0.020.0x
Asset TurnoverN/AN/A0.000.0x0.000.0x0.000.0x0.020.0x0.010.0x0.020.0x
FCF MarginN/AN/AN/AN/AN/A-2966.6%N/AN/A

Not reported in any period shown, so not listed: Gross Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Frequently Asked Questions

What is SPRBD's annual revenue?

SPRBD (SPRBD) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SPRBD's revenue growing?

SPRBD (SPRBD) revenue declined by 100.0% year-over-year, from $4.9M to $0 in fiscal year 2025.

Is SPRBD profitable?

No, SPRBD (SPRBD) reported a net income of -$39.0M in fiscal year 2025.

SPRBD (SPRBD) reported diluted earnings per share of -$50.83 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SPRBD (SPRBD) had EBITDA of -$36.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, SPRBD (SPRBD) had $48.9M in cash and equivalents against $0 in long-term debt.

SPRBD (SPRBD) has a return on equity of -91.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

SPRBD (SPRBD) recorded an outflow of $33.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

SPRBD (SPRBD) had $53.0M in total assets as of fiscal year 2025, including both current and long-term assets.

SPRBD (SPRBD) invested $19.5M in research and development during fiscal year 2025.

SPRBD (SPRBD) had 1M shares outstanding as of fiscal year 2025.

SPRBD (SPRBD) had a current ratio of 5.17 as of fiscal year 2025, which is generally considered healthy.

SPRBD (SPRBD) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

SPRBD (SPRBD) had a return on assets of -73.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

SPRBD (SPRBD) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

SPRBD (SPRBD) reported a net loss of $39.0M while operations used $33.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

SPRBD (SPRBD) reported an operating loss of $36.5M against $90K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top